$30.49 -0.51 (-1.65%)
11/27/2009 1:00 PM

Medivation, Inc. (MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Featured Broker Partners